Ep 47. Relapse After Cessation Of Weekly Tocilizumab For Giant Cell Arteritis Talking Rheumatology Research podcast

Innhold levert av British Society for Rheumatology. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av British Society for Rheumatology eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Talking Rheumatology Research »
Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis

19d ago 10:32

Del

MP3•Episoder hjem

Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients.

Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better access to diagnostic tools, and a multidisciplinary approach to managing this condition.

You can read this article [https://doi.org/10.1093/rheumatology/kead604] in Rheumatology.

Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

47 episoder

#Fitness #Medicine #British Society For Rheumatology #Rheumatology #Research #Arthritis #Lupus #Journalism #Disease #Science #Myositis #Vasculitis #Bsr